Project Revival: $1M (Revenue) Regenerative Medicine Hub Offering Stem Cell, Anti-Aging, PRP, and Advanced Wellness Therapies Located in Chicago

M&A Healthcare Advisors (“MAHA”) is pleased to present Project Revival (the “Company”), a pioneering regenerative medicine hub with a proven track record in cutting-edge therapies and patient-focused care.

Founded in 2018, the Company has grown into a premier destination for regenerative medicine in its market, offering a broad range of services including stem cell therapy, platelet-rich plasma (PRP) therapy, exosome therapy, and IV nutrition. The practice serves a diverse patient base seeking advanced solutions for orthopedic, anti-aging, sexual wellness, and chronic condition needs.

With a team of experienced providers, the Company delivers high-quality, outcomes-driven treatments supported by best-in-class protocols. Its reputation for innovation, patient satisfaction, and strong clinical results has led to sustained growth and expanding referral relationships.

The business operates from a state-of-the-art facility and is positioned for scalable expansion through additional locations, strategic partnerships, and enhanced marketing initiatives. All employees are expected to remain post-transaction, ensuring continuity for both patients and operations.


2023

2024

TTM (Sep 2025)

2025 YTD Jan-Sep (9mos)

Revenue

944k

709k

889k

763k

EBITDA

108k

94k

120k

146k

EBITDA Margin

11%

13%

13%

19%

The owners have retained MAHA to explore a sale of the business. They are seeking a buyer who can continue to scale the model regionally and nationally while maintaining the Company’s reputation for quality and patient-centered care.

Read More

Project Aura: $1.9M Adj. EBITDA Plastic Surgery & MedSpa Provider

M&A Healthcare Advisors (“MAHA”) is pleased to present Project Aura (the “Company”), a multi-site, cosmetic surgery and medical spa service provider located in Tennessee.

With a team of more than 24 employees, the Company serves over 13,000 patients annually, including more than 2,200 recurring patients. For the year-to-date period ending June 2025, revenue is split approximately 60% surgical services and 40% non-surgical services, with nearly 100% derived from private pay.


2022

2023

2024

TTM (June 2025)

Revenue

5.6 M

6.1 M

6.1 M

5.9 M

Adj. EBITDA

1.9 M

2.1 M

2.1 M

1.9 M

Adj. EBITDA Margin

34%

34%

35%

32%

The owners of the Company have retained M&A Healthcare Advisors (“MAHA”) to identify a strategic or financial partner to support the continued growth and scalability of Project Aura. All employees, including the current owner, will remain with the business post-transaction.

For Institutional Investor Use Only

Read More

Project Alpha: $550k (AEBITDA) Private Pay Mental Health and Mentorship Provider Located in the Northeast

M&A Healthcare Advisors (“MAHA”) is pleased to present Project Alpha (the “Company”), a multi-location, northeast-focused mental health and mentorship provider for young adults between the ages of approximately 16–30.

With a team of 20+ employees, the Company has provided services to over 236 unique clients through July 2025 and over 1,500 clients throughout its 10+ year history. Care programs typically run for six months but are fully customizable to meet each individual’s needs. Services are delivered both in-clinic and via telehealth, allowing for flexible and accessible care.

 The Company operates on a 100% private-pay model and focuses on young males facing a variety of emotional, behavioral, and developmental challenges. Referral partnerships are diverse and active, including word-of-mouth, schools, physicians, therapists, and educational consultants.


2022

2023

2024

TTM (July 2025)

Revenue

1.81 M

2.35 M

2.37 M

2.45 M

Adj. EBITDA

0.21 M

0.46 M

0.4 M

0.55 M

Adj. EBITDA Margin

11%

20%

17%

22%

The owners have retained MAHA to explore the sale of the business. They are looking to transition the business to buyers looking to expand the model to other regions of the United States. All employees are expected to remain with the business post-transaction.

Read More

Project Cove: $700k Adj. EBITDA Hospice Located in Northern San Diego

M&A Healthcare Advisors (“MAHA”) is pleased to present Project Cove (the “Company”), a CHAP-accredited hospice provider that primarily serves patients in Northern San Diego County and currently holds a license to provide services throughout all of Southern California.

With a team of 18+ employees and staff, the Company serviced 128 Medicare covered, hospice patients in 2024. The average monthly census from 2023-2024 was 26 patients while YTD through May 2025 has grown to 29 patients.


2022

2023

2024

TTM (Apr 2025)

Revenue

1.3 M

1.9 M

2.1 M

2.5 M

Adj. EBITDA

0.1 M

0.3 M

0.4 M

0.7 M

Adj. EBITDA Margin

11%

18%

18%

27%

Ownership does not maintain an active role in the day-to-day operations of the business. They have engaged MAHA to explore a potential transaction and are open to ongoing involvement post-close, including a transitional role. If you would like to learn more about Project Cove, please sign our NDA via the link below.

Read More

Project Cardiff: $8.1M Adj. EBITDA Home Health, Hospice, & Home Care Provider Located in Southern California

M&A Healthcare Advisors (“MAHA”) is pleased to present Project Cardiff (the “Company”), a Joint Commission accredited, multi-location provider delivering home health, hospice, and home care services across Southern California.

 With a team of 570+ employees and staff, the Company completed 69,000+ home health visits and served over 1,000 hospice patients in 2024. Their 2024 revenue was comprised of 54% hospice, 45% home health, and 1% home care with over 90% of the population covered by Medicare.


2023

2024

TTM (May 2025)

Revenue

36.2 M

39.3 M

40.3 M

Gross Profit

20.8 M

22.4 M

23 M

Adj. EBITDA

7.8 M

8.3 M

8.1 M

Adj. EBITDA Margin

21.6%

21.1%

20.1%

Ownership has engaged MAHA to explore a potential transaction and is open to ongoing involvement post-close, including a transitional role. If you would like to learn more about Project Cardiff, please sign our NDA via the link below.

Read More

Project Gamma: $1.3M Adj. EBITDA In-Network Outpatient Diagnostic Imaging Service Provider

M&A Healthcare Advisors (“MAHA”) is pleased to present Project Gamma (the “Companies”), a portfolio of ACR accredited, diagnostic imaging centers.  The Companies, through their 4 centers, have been providing advanced medical imaging services in South Florida for over 30 years. Utilizing state-of-the-art technology, the Companies offer a comprehensive range of imaging modalities, including biopsy, computed tomography, magnetic resonance imaging, 3D mammography, nuclear medicine, PET/CT scans, ultrasound, and more.

From 2022 to 2024, the Companies have provided services to an average of 39,000 patients annually and are in-network with over 35 insurance companies. With over 50 employees and a 9K+ physician referral base, the Companies are well positioned for continued growth.

Financial Overview

 

 2023  2024
 Revenue  8.2M  8.8M
 Gross Profit  5.1M  5.7M
 Adjusted EBITDA  .3M  1.3M
 EBITDA Margin  3%  15%

 

Our clients, the ownership group, have retained MAHA to explore a transaction. Management and ownership are open to evaluating their roles and responsibilities post-transaction. If you would like to learn more about Project Gamma, please sign our NDA via the link below.

Read More

Project Ruby: $2.1M Revenue Outpatient Mental Health Provider Located in Oregon

M&A Healthcare Advisors (“MAHA”) is pleased to present an outpatient mental health provider located in Oregon. The company was formed nearly 10 years ago and offers services to both children & adults with a variety of conditions such as trauma, attachment, grief, neurodiversity (ADD/ADHD, Autism), couples issues, and more. In 2024, roughly 52% of revenue came from Medicaid, 44% came from commercial insurance, with the remaining 2% consisting of self-pay. They have a current patient census of 350+ and have 16+ employees.


2023

2024

TTM (Mar 25)

Revenue

1.8 M

1.88 M

2.1 M

Gross Profit

0.64 M

0.58 M

0.68 M

Adj. EBITDA

0.5 M

0.42 M

0.5 M

Adj. EBITDA Margin

27%

23%

24%

The decrease in EBITDA margin from 2023-2024, stems from higher employee costs. Our clients are open to remaining with the business through a transitionary period. All employees, including additional management, are expected to remain with the company post-acquisition.

The reader agrees to the provisions set forth on those certain “Disclaimers” located at https:/www.finalis.com/disclaimers and the terms thereof are incorporated by reference as though fully set forth herein, and references therein to (i) “Company” means the entity in connection with this transaction (together with its affiliates, subsidiaries, successors and assigns), (ii) “Banker” means Michael Moran and (iii) “Bank” means M&A Healthcare Advisors. Securities are offered through Finalis Securities, LLC, member FINRA/SIPC. M&A Healthcare Advisors and Finalis Securities are separate, unaffiliated entities.

Read More

Project Juniper: Growing $2.2 Million AEBITDA In-Network Applied Behavioral Analysis (“ABA”) Company with locations in the Northeast, North Carolina, & Michigan

M&A Healthcare Advisors (“MAHA”) is pleased to present a multi-location Applied Behavioral Analysis (“ABA”) company with locations in the Northeast, North Carolina, & Michigan. Through its 10+ year lifespan, the company has grown organically and through strategic acquisitions. Their services include School, Clinic, & Home-Based therapies, Early Intervention, Teen & Transition services, and Caregiver + School Support services.

The leadership team has deep clinical roots working with children with autism and utilizes an established systematic approach to improve client outcomes. They are also well-positioned to scale within in their current geography and into neighboring markets.

Revenue is generated through Medicaid (57%), Schools (22%), and In-Network Insurance Contracts (21%). TTM (Nov 23 – Oct 24) average census is 166, they employ 15 BCBA’s and have over 140 W2 employees. The clinics at which they provide services are leased properties.

Financial Overview

2022

2023

TTM-Oct 24

 Revenue

8.7M

9.1M

9.4M

Gross Profit

3.4M

3.2M

3.6M

AEBITDA

1.7M

1.9M

2.2M

AEBITDA Margin

19%

20%

23%

Our clients, the ownership group, have no active involvement in day-to-day operations. All employees, including the established management team, are expected to remain with the company post-acquisition.

Read More

Project Ted: $3.4 Million AEBITDA Hospice Provider Located in Southern California

After pausing the prior sale process to conduct a limited Quality of Earnings review and Cap analysis, Project Ted is being offered for acquisition once again. Project Ted is an ACHC accredited hospice provider with two locations in Southern California. The business was established in 2012 and has over 60 employees. The ADC for FY 2024 was 128.

From 2023 through December of 2024, approximately 87% of the revenue can be attributed to Medicare.

Financial Overview:

 

2022 2023 2024
Net Revenue 12.4 10.8 10.5
Gross Profit 7.3 7.0 6.7
Adj. EBITDA 1.3 1.8 3.4

 

Ownership consists of two (2) owners who each hold 50% of the agency. One owner functions as the Administrator while the other has a reduced role in day-to-day operations. Ownership is collectively looking for a full exit to explore other opportunities. Both owners are available to assist in a transitionary period and all employees, including additional management, are expected to remain.

The reader agrees to the provisions set forth on those certain “Disclaimers” located at https:/www.finalis.com/disclaimers and the terms thereof are incorporated by reference as though fully set forth herein, and references therein to (i) “Company” means the entity in connection with this transaction (together with its affiliates, subsidiaries, successors and assigns), (ii) “Banker” means Andre Ulloa and (iii) “Bank” means M&A Healthcare Advisors. Securities are offered through Finalis Securities, LLC, member FINRA/SIPC. M&A Healthcare Advisors and Finalis Securities are separate, unaffiliated entities.

Read More